Beyond SSRIs: Antipsychotic Augmentation in OCD

<p>In this episode, you'll discover the preferred second-generation antipsychotics for augmenting treatment for obsessive-compulsive disorder: Risperidone and aripiprazole. We discuss their effectiveness and important considerations when choosing between them. What factors should clinicians weigh when deciding on an augmentation strategy?</p> <p>Faculty: David Osser, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC240" target="_blank" rel="noopener"><strong>Learn more about our memberships here</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/publication/algorithm-for-the-pharmacotherapy-of-obsessive-compulsive-disorder-2676?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC240" target="_blank" rel="noopener"><strong>Earn 1.25 CME: Algorithm for the Pharmacotherapy of Obsessive-Compulsive Disorder</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/section/node-4-ssri-augmentation-with-sga-2676-5277?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC240" target="_blank" rel="noopener"><strong>Node 4: SSRI Augmentation With SGA</strong></a></li> </ul>